Kendall Capital Management

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1731372 ROCKVILLE, MD

Position in AMRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$606,109

+$167,144 QoQ

Shares Held

35,015

-0.8% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#164

of 305 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kendall Capital Management holds $9,113,830 across 5 Drug Manufacturers - Specialty & Generic names. AMRX ranks #5 (6.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	217,370	$3,451,835
2	UTHR	UNITED THERAPEUTICS Corp	5,881	$3,186,502
3	COLL	Collegium Pharmaceutical, Inc	34,730	$1,257,226
4	ANIP	Ani Pharmaceuticals Inc	7,395	$612,158
5	AMRX	Amneal Pharmaceuticals, Inc. This page	35,015	$606,109

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$606,109	35,015	-0.8%	Shares	Sole	2026-08-12
2026-03-31	$438,965	35,315	+3.1%	Shares	Sole	2026-04-24
2025-12-31	$431,739	34,265	+33.5%	Shares	Sole	2026-01-16
2025-09-30	$256,956	25,670	+34.4%	Shares	Sole	2025-11-13
2025-06-30	$154,559	19,105	—	Shares	Sole	2025-07-16
No filing history on record for this holder in this stock.